Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy

Journal of Clinical Investigation

Volumn 116, Issue 12, 2006, Pages 3266-3276

  Ritter, Matthew R ^a   Banin, Eyal ^a,b   Moreno, Stacey K ^a   Aguilar, Edith ^a   Dorrell, Michael I ^a   Friedlander, Martin ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; MICROGLIA; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROGLIA; MYELOID PROGENITOR CELLS; RETINA; RETINAL DISEASES; RETINAL NEOVASCULARIZATION; WOUND HEALING;

EID: 33845297656     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29683     Document Type: Article

References (44)

1. Das, A., and McGuire, P.G. 2003. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog. Retin. Eye Res. 22:721-748.
2. Ryan, S.J., Hinton, D., Schachat, A., and Wilkinson, P. 2006. Retina. Elsevier. Philadelphia, Pennsylvania, USA. 3104 pp.
3. Aiello, L.P. 2005. Angiogenic pathways in diabetic retinopathy. N. Engl. J. Med. 353:839-841.
4. Bressler, N.M., and Altaweel, M. 2005. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology. 113:23-28.
5. Jonas, J.B., Kreissig, I., and Degenring, R. 2005. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog. Retin. Eye Res. 24:587-611.
6. Mason, J.O., 3rd, et al. 2005. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy. Am. J. Ophthalmol. 140:231-235.
7. Schmidt-Erfurth, U., Niemeyer, M., Geitzenauer, W., and Michels, S. 2005. Time course and morphology of vascular effects associated with photodynamic therapy. Ophthalmology. 112:2061-2069.
8. Van Wijngaarden, P., Coster, D.J., and Williams, K.A. 2005. Inhibitors of ocular neovascularization: promises and potential problems. JAMA. 293:1509-1513.
9. Otani, A., et al. 2002. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8:1004-1010.
10. Otani, A., et al. 2004. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J. Clin. Invest. 114:765-774. doi:10.1172/JCI200421686.
11. Dorrell, M.I., Otani, A., Aguilar, E., Moreno, S.K., and Friedlander, M. 2004. Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina. Blood. 103:3420-3427.
12. Kocher, A.A., et al. 2001. Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-436.
13. Orlic, D., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature. 410:701-705.
14. Smith, L.E., et al. 1994. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35:101-111.
15. Connolly, S.E., Hores, T.A., Smith, L.E., and D'Amore, P.A. 1988. Characterization of vascular development in the mouse retina. Microvasc. Res. 36:275-290.
16. Dorrell, M.I., Aguilar, E., and Friedlander, M. 2002. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest. Ophthalmol. Vis. Sci. 43:3500-3510.
17. Banin, E., et al. 2006. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest. Ophthalmol. Vis. Sci. 47:2125-2134.
18. Semenza, G.L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3:721-732.
19. Clausen, B.E., Burkhardt, C., Reith, W., Renkawitz, R., and Forster, I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265-277.
20. Cramer, T., et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 112:645-657.
21. Guillemin, G.J., and Brew, B.J. 2004. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75:388-397.
22. Hume, D.A., Perry, V.H., and Gordon, S. 1983. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J. Cell Biol. 97:253-257.
23. Provis, J.M., Penfold, P.L., Edwards, A.J., and van Driel, D. 1995. Human retinal microglia: expression of immune markers and relationship to the glia limitans. Glia. 14:243-256.
24. Van Rooijen, N., and Sanders, A. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods. 174:83-93.
25. Schmidt-Weber, C.B., et al. 1996. Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. J. Leukoc. Biol. 60:230-244.
26. Cursiefen, C., et al. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inf lammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113:1040-1050. doi:10.1172/JCI200420465.
27. Kerbel, R., and Folkman, J. 2002. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer. 2:727-739.
28. Grant, M.B., et al. 2002. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8:607-612.
29. Espinosa-Heidmann, D.G., Caicedo, A., Hernandez, E.P., Csaky, K.G., and Cousins, S.W. 2003. Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44:4914-4919.
30. Ishida, S., et al. 2003. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J. Exp. Med. 198:483-489.
31. Davies, M.H., Eubanks, J.P., and Powers, M.R. 2006. Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina. Mol. Vis. 12:467-477.
32. Laflamme, M.A., and Murry, C.E. 2005. Regenerating the heart. Nat. Biotechnol. 23:845-856.
33. Kinnaird, T., Stabile, E., Burnett, M.S., and Epstein, S.E. 2004. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ. Res. 95:354-363.
34. Grunewald, M., et al. 2006. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 124:175-189.
35. Dorrell, M.I., Aguilar, E., Weber, C., and Friedlander, M. 2004. Global gene expression analysis of the developing postnatal mouse retina. Invest. Ophthalmol. Vis. Sci. 45:1009-1019.
36. Ritter, M.R., Dorrell, M.I., Edmonds, J., Friedlander, S.F., and Friedlander, M. 2002. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc. Natl. Acad. Sci. U. S. A. 99:7455-7460.
37. Penn, J.S., et al. 2006. Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 47:405-414.
38. Pahl, H.L., Rosmarin, A.G., and Tenen, D.G. 1992. Characterization of the myeloid-specific CD11b promoter. Blood. 79:865-870.
39. Fleming, T.J., Fleming, M.L., and Malek, T.R. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151:2399-2408.
40. Malorny, U., Michels, E., and Sorg, C. 1986. A monoclonal antibody against an antigen present on mouse macrophages and absent from monocytes. Cell Tissue Res. 243:421-428.
41. Landmann, R., Wesp, M., and Obrecht, J.P. 1991. Cytokine regulation of the myeloid glycoprotein CD14. Pathobiology. 59:131-135.
42. Junttila, I., Bourette, R.P., Rohrschneider, L.R., and Silvennoinen, O. 2003. M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-delta and expression of Pkare. J. Leukoc. Biol. 73:281-288.
43. Kina, T., et al. 2000. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol. 109:280-287.
44. Coffman, R.L. 1982. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:5-23.